




exocrine part of the pancreas. Revealed lower optical density of cytoplasm in insulin+ 
cells in liver and exocrine part of the pancreas, compared to β-cells, indicates relatively 
low content of insulin in these cells and shows its lower functional activity. 
Conclusion. In T2D deficiency of insulin can be compensated for by the 
formation of new cells, producing insulin. Reprogramming of hepatocytes and cells of 
exocrine part of the pancreas into insulin+ cells is a potentially approach to generate 
new insulin-producing cells. An increase both the number of insulin+ hepatocytes and 
quantity in them of a transcription factor PDX1, which regulates expression of insulin 
gene, is a perspective way in in the development of new methods and approaches in 
the treatment of diabetes mellitus.  
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Isoflavones are a type of polyphenol found in soybeans, chickpeas, fava beans, 
pistachios, peanuts, nuts, and other fruits [1]. Isoflavones include daidzin, genistin, 
biochanin A, and formononetin [2]. Isoflavones can inhibit growth of breast, uterine, 





Cancer is a leading cause of morbidity and mortality worldwide. Deaths from 
cancer worldwide are projected to reach over 13 million in 2030 [6]. Chemotherapy is 
a type of cancer treatment that uses one or more chemotherapeutic agents [7]. 
Doxorubicin, an anthracycline antibiotic is among the most widely used anticancer 
agents for treatment of various cancer types [8]. Doxorubicin interacts with the DNA 
by intercalation thus, inhibiting macromolecular biosynthesis. This further inhibits the 
progression of the enzyme topoisomerase II, and relaxes supercoils in DNA for 
transcription and thereby inducing cell cycle arrest [9]. Moreover, doxorubicin 
treatment is associated with senescent markers in different cancer types such as 
upregulation of P-p53 (Ser15) and p21 expression along with increased cell positive 
cells bearing senescence associated- β-galactosidase (SA β-gal) activity and cell cycle 
arrest [10, 11].  
Elimination of senescent cancer cells is an important objective in doxorubicin 
therapy because it my replace if not swiped. To date, our previous in vitro study stated 
the senolytic effect of thymoquinone (ingredient of Nigella sativa seeds), curcumin 
(ingredient of Curcuma longa seeds), and caffeine (ingredient of coffee bean seeds) 
against senescent, induced by doxorubicin, colon (HCT116) and breast (MCF7) cancer 
cell lines [10]. Also, we recognized the senolytic effect of costulonide (ingredient of 
Costus speciosus) against senescent HCT116 and MCF7 cancer cell lines (in press). 
Therefore, we seek to investigate the senolytic effects of isoflavones to eliminate the 
senescent cells that mediated by doxorubicin. Also, if able to protect the normal body 






Figure 1. Proposal idea 
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STRUCTURAL BASIS FOR THE DESIGN OF KINASE INHIBITORS 
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Structural basis for the design of kinase inhibitors in cancer chemotherapy and 
neurodegenerative diseases will be presented and discussed. The main accent will be 
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